Phibro Animal Health (PAHC) Cash & Equivalents (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Cash & Equivalents of $54.9 million for Q1 2026, down 8.99% year-over-year from $60.4 million in Q1 2025, and down 1.0% quarter-over-quarter from $55.5 million in Q4 2025.
Phibro Animal Health (PAHC) Cash & Equivalents (2013 - 2026) Analysis & Trends
Phibro Animal Health's Cash & Equivalents history runs 14 years deep, the most recent figure standing at $54.9 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 8.99% year-over-year to $54.9 million; the TTM figure through Mar 2026 stood at $54.9 million (down 8.99% YoY), while the FY2025 annual figure was $68.0 million, down 3.65% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $54.9 million, down from $55.5 million in the prior quarter.
- The five-year high for Cash & Equivalents was $76.3 million in Q3 2022, with the low at $33.0 million in Q4 2023.
- The 5-year median for Cash & Equivalents is $60.4 million (2025), against an average of $58.6 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 51.81% in 2023, then jumped 103.44% in 2024.
- Phibro Animal Health's Cash & Equivalents stood at $68.4 million in 2022, then sank by 51.81% to $33.0 million in 2023, then surged by 103.44% to $67.1 million in 2024, then retreated by 17.28% to $55.5 million in 2025, then fell by 1.0% to $54.9 million in 2026.
- Business Quant data shows PAHC's Cash & Equivalents at $54.9 million in Q1 2026, $55.5 million in Q4 2025, and $72.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 54.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.93 Mn |
| Dec 31, 2025 | 55.49 Mn |
| Sep 30, 2025 | 72.77 Mn |
| Jun 30, 2025 | 68.04 Mn |
| Mar 31, 2025 | 60.35 Mn |
| Dec 31, 2024 | 67.07 Mn |
| Sep 30, 2024 | 51.84 Mn |
| Jun 30, 2024 | 70.61 Mn |
| Mar 31, 2024 | 50.23 Mn |
| Dec 31, 2023 | 32.97 Mn |
| Sep 30, 2023 | 43.15 Mn |
| Jun 30, 2023 | 41.28 Mn |
| Mar 31, 2023 | 37.24 Mn |
| Dec 31, 2022 | 68.42 Mn |
| Sep 30, 2022 | 76.28 Mn |
| Jun 30, 2022 | 74.25 Mn |
| Mar 31, 2022 | 70.75 Mn |
| Dec 31, 2021 | 63.39 Mn |
| Sep 30, 2021 | 41.18 Mn |
| Jun 30, 2021 | 50.21 Mn |